We are happy with the FDA’s approval of this new drug as it gives a promising new choice available to those experiencing this debilitating autoimmune disease, especially those who have failed other forms of treatment. Of the more than 80 autoimmune diseases, RA is one of the most common and one of the more difficult autoimmune rheumatic illnesses to control. It is a progressive disease that can affect many joints, most commonly the small joints of the hands.In some research areas, it really is as low as 1-in-10. A large number of promising research ideas that are proposed every year are never funded. Medical study in the United States is in crisis, said Pat White, President of Work for NIH and former Associate Director for Legislative Plan and Analysis at NIH. Simple scientific discovery funded by NIH qualified prospects to fresh treatments for sufferers facing life-threatening illnesses. We are missing critical possibilities to discover therapies and cures for diseases like cancer, Alzheimer's, cardiovascular disease, diabetes, and countless other circumstances. Many issues are at stake: Advancing Cures: Illnesses like cancer, stroke, and mental illness touch each of us.